TuHURA Biosciences, Inc. (HURA)

TuHURA Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2024	FY 2024	FY 2024	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022
Net Income	-26.63	-21.68	-8.32	-29.32	-14.65	-14.65
Depreciation & Amortization	1.14	0.12	0.06	0.18	3.29	3.29
Stock-Based Compensation	4.63	1.96	0.61	0.48	1.49	1.76
Other Adjustments	8.14	1.59	0.19	16.22	0.2	0
Changes in Accounts Payable	2	3.64	-0.58	0.34	-0.44	-0.44
Changes in Other Operating Activities	0.17	-0.36	0.87	0.15	-1.75	-0.05
Operating Cash Flow	-23.58	-14.73	-7.18	-11.95	-11.87	-11.87
Capital Expenditures	0.13	-0.06	-0.02	-0.08	-0.23	-0.25
Payments for Business Acquisitions	-1.23	-5.99	-	-1.22	-	-
Other Investing Activities	-1.11	-	-	-	-	-
Investing Cash Flow	-7.13	-6.05	-0.02	-1.3	-0.23	-1.45
Long-Term Debt Issued	-	28.57	-	2.69	-	-
Net Long-Term Debt Issued (Repaid)	-	28.57	-	2.69	-	-
Issuance of Common Stock	12.78	7.05	10.58	-	1.9	-
Repurchase of Common Stock	-0.01	-	-	-0.02	-	-
Net Common Stock Issued (Repurchased)	12.76	7.05	10.58	-0.02	1.9	-
Preferred Share Dividends Paid	-0.01	-	-0.01	-	-0.01	-0.01
Other Financing Activities	-1.74	-5.84	-	-	-0.04	-
Financing Cash Flow	13.42	29.77	10.57	2.66	1.85	1.85
Net Cash Flow	-11.47	8.99	3.37	-10.59	-10.25	-10.25
Free Cash Flow	-26.32	-14.79	-7.2	-12.03	-12.1	-12.12
Free Cash Flow Per Share	-0.30	-0.28	-9.56	-1.01	-261.35	-
Levered Free Cash Flow	-22.97	9.26	-8.18	-26.05	-14.16	2.55
Unlevered Free Cash Flow	-34.56	-14.3	0.33	-29.18	0.86	2.54

Updated Nov 14, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q